Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACK-AMI: Rosuvastatin Loading and Hydration for CIAKI Prevention in STEMI
NCT03526367Phase 4Withdrawn
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Feb 2019
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in contrast-induced acute kidney injury (CI-AKI), sponsored by General Hospital of the Northern Theater Command. Planned start Feb 2019; status: withdrawn.
02
Drugs
rosuvastatin
03
Conditions
contrast-induced acute kidney injury (CI-AKI)
Beyond the preview
Go deeper on NCT03526367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03526367.